Clinical effects of naftopidil on nocturia associated with benign prostatic hyperplasia
We studied the efficacy of naftopidil (50 mg/day) on nocturia associated with benign prostatic hyperplasia in 35 patients (62-80 years old). The patients had BPH > 20 ml, nocturia, more than 3 times, international prostate symptom score (IPSS) > 7, quality of life score (QOL) < 1, and maxim...
| Veröffentlicht in: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 49(2003), 8 vom: 07. Aug., Seite 445-9 |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | , , , , , |
| Format: | Aufsatz |
| Sprache: | Japanese |
| Veröffentlicht: |
2003
|
| Zugriff auf das übergeordnete Werk: | Hinyokika kiyo. Acta urologica Japonica |
| Schlagworte: | Clinical Trial English Abstract Journal Article Multicenter Study Adrenergic alpha-Antagonists Naphthalenes Piperazines naftopidil R9PHW59SFN |
| Zusammenfassung: | We studied the efficacy of naftopidil (50 mg/day) on nocturia associated with benign prostatic hyperplasia in 35 patients (62-80 years old). The patients had BPH > 20 ml, nocturia, more than 3 times, international prostate symptom score (IPSS) > 7, quality of life score (QOL) < 1, and maximum flow rate (Qmax) < 15 ml/sec. They received naftopidil for more than 6 weeks. IPSS, QOL, Qmax, micturition volume, and side effects were analyzed. Naftopidil was effective for nocturia associated with benign prostatic hyperplasia, especially when taken at night |
|---|---|
| Beschreibung: | Date Completed 17.10.2003 Date Revised 15.11.2012 published: Print Citation Status MEDLINE |
| ISSN: | 0018-1994 |